Author/Authors :
Lewis, KCL PATH - Reproductive Health Program, USA , Tsu, VD PATH - Reproductive Health Program, USA , Dawa, A PATH, Kenya , Kidula, NA Ministry of Health - Reproductive Health Department, Kenya , Chami, IN PATH, Kenya , Sellors, JW McMaster University - Department of Family Medicine, Canada , Sellors, JW PATH - Reproductive Health Program, USA , lewis, k.c.l. path,p.o. box 900922,seattle, United States , tsu, v.d. path,p.o. box 900922,seattle, United States , dawa, a. path, Kenya , kidula, n.a. reproductive health department,ministry of health, Kenya , chami, i.n. path, Kenya , sellors, j.w. path,p.o. box 900922,seattle,wa 98109,united states,department of family medicine, Canada
Abstract :
Background: Only about one in seven visual inspection with acetic acid (VIA)-positive women has high-grade disease; further confirmatory testing could rule out false positives. Objectives: To determine if visual inspection with Lugol’s iodine (VILI) or visual inspection with acetic acid and magnification (VIAM) can accurately confirm the presence of disease among rural Kenyan women referred to a district hospital because of a VIA-positive result at a primary health facility. Methods: Referred women received cervical cytology and either VILI and/or VIAM as triage methods. All women were assessed by colposcopy and biopsied, if necessary. Results: Of the 490 VIA-positive subjects referred, 332 (68%) attended the district hospital and received at least one of two triage tests and cervical cytology. The sensitivity and specificity for histologically-confirmed CIN 2 and 3 were 93% (14/15) and 32% (52/161) for VIAM; 100% (3/3) and 77% (49/64) for VILI; and 80% (16/20) and 48% (110/228) for cervical cytology. VILI reduced the number of false-positive screening results by 73%, without missing any true positives. Conclusions: VILI had comparable sensitivity and significantly higher specificity compared to VIAM and cervical cytology. VILI may be a promising triage test for screen-positive women in low-resource settings; additional research is required.
Keywords :
cervical cytology , mass screening , neoplasms , precancerous conditions , uterine cervical neoplasms , developing countries.